These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 3156105

  • 21. Oral retinoid for psoriasis. A report of a double blind study.
    Pettit JH.
    Acta Derm Venereol Suppl (Stockh); 1979; 59(85):133-6. PubMed ID: 393035
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE, Ellis CN, Campbell JP, Case PC, Voorhees JJ.
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis.
    Ruzicka T, Sommerburg C, Braun-Falco O, Köster W, Lengen W, Lensing W, Letzel H, Meigel WN, Paul E, Przybilla B.
    Arch Dermatol; 1990 Apr; 126(4):482-6. PubMed ID: 2138875
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A clinical evaluation of the effects of an aromatic retinoid (Tigason), combination of retinoid and PUVA, and PUVA alone in severe psoriasis.
    Lauharanta J, Juvakoski T, Lassus A.
    Br J Dermatol; 1981 Mar; 104(3):325-32. PubMed ID: 7011359
    [Abstract] [Full Text] [Related]

  • 27. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
    Ledo A, Martín M, Geiger JM, Marrón JM.
    Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
    [Abstract] [Full Text] [Related]

  • 28. [Successful use of isotretinoin in type Zumbusch generalized pustular psoriasis following recovered etretinate-induced hepatitis].
    Marhold I, Duschet P, Schwarz T, Gschnait F.
    Hautarzt; 1991 Sep; 42(9):580-3. PubMed ID: 1938411
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. An overview of the retinoids.
    Boyd AS.
    Am J Med; 1989 May; 86(5):568-74. PubMed ID: 2653031
    [Abstract] [Full Text] [Related]

  • 32. Etretin therapy for severe psoriasis. Evaluation of initial clinical responses.
    Kingston TP, Matt LH, Lowe NJ.
    Arch Dermatol; 1987 Jan; 123(1):55-8. PubMed ID: 2948451
    [Abstract] [Full Text] [Related]

  • 33. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL, Blummel JJ, Kerkhof PC, Gerritsen RM.
    Eur J Dermatol; 2000 Jan; 10(7):517-21. PubMed ID: 11056421
    [Abstract] [Full Text] [Related]

  • 34. Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: a double-blind trial.
    van der Rhee HJ, Tijssen JG, Herrmann WA, Waterman AH, Polano MK.
    Br J Dermatol; 1980 Feb; 102(2):203-12. PubMed ID: 6992834
    [Abstract] [Full Text] [Related]

  • 35. [Retinoids: the new status. Maintenance therapy, disorders of resorption in "non-responders", interactions and interferences with drugs, treatment of children and bone toxicity, acitetin and 13-cis-acitretin].
    Orfanos CE.
    Hautarzt; 1989 Mar; 40(3):123-9. PubMed ID: 2523875
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. International studies of the efficacy of etretinate in the treatment of psoriasis.
    Ehmann CW, Voorhees JJ.
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):692-6. PubMed ID: 7040512
    [Abstract] [Full Text] [Related]

  • 38. Hepatotoxic reactions in a patient treated with etretinate.
    Weiss VC, West DP, Ackerman R, Robinson LA.
    Arch Dermatol; 1984 Jan; 120(1):104-6. PubMed ID: 6691707
    [Abstract] [Full Text] [Related]

  • 39. Teratogenicity of steady-state concentrations of etretinate and metabolite acitretin maintained in maternal plasma and embryo by intragastric infusion during organogenesis in the mouse: a possible model for the extended elimination phase in human therapy.
    Löfberg B, Reiners J, Spielmann H, Nau H.
    Dev Pharmacol Ther; 1990 Jan; 15(1):45-51. PubMed ID: 2147001
    [Abstract] [Full Text] [Related]

  • 40. Retinoids.
    Roenigk HH.
    Cutis; 1987 Apr; 39(4):301-5. PubMed ID: 3472776
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.